Ping An Biomedical Co., Ltd. (PASW) — SEC Filings
Ping An Biomedical Co., Ltd. (PASW) — 8 SEC filings. Latest: 6-K (Nov 28, 2025). Includes 8 6-K.
View Ping An Biomedical Co., Ltd. on SEC EDGAR
Overview
Ping An Biomedical Co., Ltd. (PASW) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Oct 14, 2025: Ping An Biomedical Co., Ltd. announced on October 14, 2025, that its Chairman and Chief Executive Officer, Mr. Jianhua Li, has resigned from his positions. The company also stated that Mr. Jianhua Li has resigned from the board of directors. The filing does not specify a replacement for Mr. Li.
Sentiment Summary
Across 8 filings, the sentiment breakdown is: 8 neutral. The dominant filing sentiment for Ping An Biomedical Co., Ltd. is neutral.
Filing Type Overview
Ping An Biomedical Co., Ltd. (PASW) has filed 8 6-K with the SEC between Jul 2025 to Nov 2025.
Recent SEC Filings (8)
| Date | Form | Description | Risk |
|---|---|---|---|
| Nov 28, 2025 | 6-K | 6-K Filing | |
| Oct 14, 2025 | 6-K | Ping An Biomedical CEO Resigns | medium |
| Sep 29, 2025 | 6-K | Majestic Ideal Holdings Ltd. Discloses Loan and Asset Details | medium |
| Sep 26, 2025 | 6-K | Majestic Ideal Holdings Ltd Renames to Ping An Biomedical | low |
| Sep 15, 2025 | 6-K | Majestic Ideal Holdings Ltd Holds Extraordinary General Meeting | low |
| Sep 3, 2025 | 6-K | Majestic Ideal Holdings Ltd Files Form 6-K for Shareholder Meeting | low |
| Jul 29, 2025 | 6-K | Majestic Ideal Holdings CEO Resigns | medium |
| Jul 24, 2025 | 6-K | Majestic Ideal Holdings Ltd Enters Underwriting Agreement | medium |
Risk Profile
Risk Assessment: Of PASW's 7 recent filings, 0 were flagged as high-risk, 4 as medium-risk, and 3 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Key Executives
- Jianhua Li
- Ms. Li Suqin
Top Tags
management-change (2) · resignation (2) · corporate-governance (2) · loan-agreement (1) · restricted-assets (1) · supplier-risk (1) · name-change (1) · corporate-action (1) · meeting (1) · shareholder-vote (1)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Reporting Period End Date | 2025-03-31 | Period for which financial information is reported. |
| Loan Agreement Date | 2025-05-22 | Date of the one-year loan agreement with Bank of China. |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Ping An Biomedical Co., Ltd. (PASW)?
Ping An Biomedical Co., Ltd. has 8 recent SEC filings from Jul 2025 to Nov 2025, including 8 6-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of PASW filings?
Across 8 filings, the sentiment breakdown is: 8 neutral. The dominant sentiment is neutral.
Where can I find Ping An Biomedical Co., Ltd. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Ping An Biomedical Co., Ltd. (PASW) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Ping An Biomedical Co., Ltd.?
Financial highlights for Ping An Biomedical Co., Ltd. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for PASW?
Investment thesis data for PASW will be available once enriched filings are processed.
Who are the key executives at Ping An Biomedical Co., Ltd.?
Key executives identified across Ping An Biomedical Co., Ltd.'s filings include Jianhua Li, Ms. Li Suqin.
What are the main risk factors for Ping An Biomedical Co., Ltd. stock?
Of PASW's 7 assessed filings, 0 were flagged high-risk, 4 medium-risk, and 3 low-risk.
What are recent predictions and forward guidance from Ping An Biomedical Co., Ltd.?
Forward guidance and predictions for Ping An Biomedical Co., Ltd. are extracted from SEC filings as they are enriched.